GT2Cer (d20:1/24:1) is a glycosphingolipid containing three salivary acids, which can be used in the research of the pathogenesis of neurodegenerative diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.